Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 842 across all filing types
Latest filing 2023-11-16 Declaration of Voting R…
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Results of Meeting 2 pages 605.5KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'RESULTS OF ANNUAL GENERAL MEETING' and provides detailed voting results for resolutions passed at the AGM held on 17 November 2023. It references compliance with Listing Rule 3.13.2 and Corporations Act Section 251AA(2), which relate to disclosure of voting outcomes. The content is focused on the official announcement of shareholder voting results rather than the AGM materials or the full annual report. The document length is short (2754 characters) and it specifically reports the results of the AGM votes, fitting the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-11-16 English
Retirement of Director 1 page 585.7KB
Board/Management Information Classification · 100% confidence The document is a company announcement dated 17 November 2023 from Bioxyne Limited regarding the retirement of a director, Mr. N H Chua, following the Annual General Meeting. It includes statements from the Chairman and information about the company's management changes. There are no financial statements, audit details, or report publications. The content focuses solely on a change in the company's board of directors. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and does not indicate it is a report or announcement of a report publication, so it is not RPA or RNS.
2023-11-16 English
Final Director's Interest Notice 2 pages 157.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including the number and class of shares held, and notes the date the director ceased to be a director. This is a report of personal share transactions or holdings by a company director, which aligns with the definition of Director's Dealing filings. The document length is short and focused solely on director share interests, with no financial results or other report content. Therefore, the appropriate classification is Director's Dealing (DIRS).
2023-11-16 English
Change in substantial holding 2 pages 160.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and shareholdings of a substantial holder in the company BIOXYNE LIMITED, including dates and nature of transactions. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report, but a regulatory disclosure of shareholding changes.
2023-11-05 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 946.0KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX announcement dated 31 October 2023 reporting on the quarter ended 30 September 2023. It includes detailed financial and operational information such as revenue growth, cash on hand, operating profit, and cash flow statements (Appendix 4C). The presence of quarterly financial data, cash flow statements, and operational highlights for a three-month period clearly indicates this is a quarterly financial report. The document is about 15,000 characters long, which is substantive and contains actual financial data and analysis, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2023-10-30 English
BLS Builds Medicinal Business In Australia 2 pages 640.0KB
Capital/Financing Update Classification · 90% confidence The document is a company announcement dated 19 October 2023 from Bioxyne Limited regarding its subsidiary Breathe Life Sciences importing medicinal cannabis and plans for GMP certification to scale production. It contains business updates about product imports, licensing, and future plans but does not include financial statements, detailed financial performance, or regulatory filings. The document is relatively short (4203 characters) and reads as a business update or capital/financing activity related to product import and manufacturing scale-up. There is no indication of it being an earnings release, annual or interim report, or regulatory filing. The content fits best under Capital/Financing Update (CAP) as it discusses import of inventory and scaling production capabilities, which are capital-related operational updates.
2023-10-18 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.